282 related articles for article (PubMed ID: 24936518)
1. Simple molecular diagnostic method for fragile X syndrome in Egyptian patients: pilot study.
Meguid NA; Ismail MF; El-Mahdy RS; Barakat MA; El-Awady MK
Acta Biochim Pol; 2014; 61(2):259-63. PubMed ID: 24936518
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
[TBL] [Abstract][Full Text] [Related]
3. Fragile X syndrome in females - a familial case report and review of the literature.
Stembalska A; Łaczmańska I; Gil J; Pesz KA
Dev Period Med; 2016; 20(2):99-104. PubMed ID: 27442693
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
[TBL] [Abstract][Full Text] [Related]
5. Newborn, carrier, and early childhood screening recommendations for fragile X.
Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
[TBL] [Abstract][Full Text] [Related]
6. Fragile X syndrome screening of families with consanguineous and non-consanguineous parents in the Iranian population.
Pouya AR; Abedini SS; Mansoorian N; Behjati F; Nikzat N; Mohseni M; Nieh SE; Abbasi Moheb L; Darvish H; Monajemi GB; Banihashemi S; Kahrizi K; Ropers HH; Najmabadi H
Eur J Med Genet; 2009; 52(4):170-3. PubMed ID: 19361583
[TBL] [Abstract][Full Text] [Related]
7. Molecular screening for fragile X syndrome in Thailand.
Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
[TBL] [Abstract][Full Text] [Related]
8. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
[TBL] [Abstract][Full Text] [Related]
9. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening.
Hantash FM; Goos DG; Tsao D; Quan F; Buller-Burckle A; Peng M; Jarvis M; Sun W; Strom CM
Genet Med; 2010 Mar; 12(3):162-73. PubMed ID: 20168238
[TBL] [Abstract][Full Text] [Related]
10. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.
García-Alegría E; Ibáñez B; Mínguez M; Poch M; Valiente A; Sanz-Parra A; Martinez-Bouzas C; Beristain E; Tejada MI
RNA; 2007 May; 13(5):756-62. PubMed ID: 17449730
[TBL] [Abstract][Full Text] [Related]
11. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
Mandel JL; Biancalana V
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
[TBL] [Abstract][Full Text] [Related]
12. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
13. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.
Tassone F; Pan R; Amiri K; Taylor AK; Hagerman PJ
J Mol Diagn; 2008 Jan; 10(1):43-9. PubMed ID: 18165273
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the polymerase chain reaction-based screening and the Southern blot methods for identification of fragile X syndrome.
Curtis-Cioffi KM; Rodrigueiro DA; Rodrigues VC; Cicarelli RM; Scarel-Caminaga RM
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1303-8. PubMed ID: 23101592
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of molecular approach in screening for fragile X premutation cases.
Refeat MM; El Saied MM; Abdel Raouf ER
Ir J Med Sci; 2023 Oct; 192(5):2265-2272. PubMed ID: 36409419
[TBL] [Abstract][Full Text] [Related]
16. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
[TBL] [Abstract][Full Text] [Related]
18. A methylation PCR approach for detection of fragile X syndrome.
Panagopoulos I; Lassen C; Kristoffersson U; Aman P
Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
[TBL] [Abstract][Full Text] [Related]
19. Pilot fragile X screening in normal population of Taiwan.
Tzeng CC; Cho WC; Kuo PL; Chen RM
Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
[TBL] [Abstract][Full Text] [Related]
20. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
Charalsawadi C; Sripo T; Limprasert P
J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
